Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

Nelarabine is effective in inducing remission in patients with relapsed and refractory T-cell acute lymphoblastic leukemia (T-ALL) but has not been fully evaluated in those with newly diagnosed disease. From 2007 to 2014, Children's Oncology Group trial AALL0434 (ClinicalTrials.gov identifier:...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 38; no. 28; pp. 3282 - 3293
Main Authors Dunsmore, Kimberly P, Winter, Stuart S, Devidas, Meenakshi, Wood, Brent L, Esiashvili, Natia, Chen, Zhiguo, Eisenberg, Nancy, Briegel, Nikki, Hayashi, Robert J, Gastier-Foster, Julie M, Carroll, Andrew J, Heerema, Nyla A, Asselin, Barbara L, Rabin, Karen R, Zweidler-Mckay, Patrick A, Raetz, Elizabeth A, Loh, Mignon L, Schultz, Kirk R, Winick, Naomi J, Carroll, William L, Hunger, Stephen P
Format Journal Article
LanguageEnglish
Published United States American Society of Clinical Oncology 01.10.2020
Subjects
Online AccessGet full text

Cover

Loading…